FDA Women’s Health Director Susan Wood Resigns In Protest Over Plan B
This article was originally published in The Gray Sheet
Executive Summary
FDA Women's Health Director Susan Wood resigned Aug. 31 in protest over the agency's handling of Barr's Plan B emergency contraceptive application
You may also be interested in...
FDA Morale Improvement Will Be A Priority, Von Eschenbach Testifies
Acting FDA Commissioner Andrew von Eschenbach stressed his commitment to improving agency morale during his confirmation hearing
FDA Morale Improvement Will Be A Priority, Von Eschenbach Testifies
Acting FDA Commissioner Andrew von Eschenbach stressed his commitment to improving agency morale during his confirmation hearing
Women’s health at FDA
Drug center scientist Kathleen Uhl will become director of FDA's Office of Women's Health in mid-December, the agency announces Nov. 21. Theresa Toigo has served as acting head since Sept. 16 to fill a hole left by Susan Wood, who resigned in protest over the agency's handling of Barr's Plan B emergency contraceptive pill (1"The Gray Sheet" Sept. 5, 2005, p. 6)...